Immunodiagnostic Systems Hldgs PLC Upgraded to “Hold” by N+1 Singer (IDH)
Immunodiagnostic Systems Hldgs PLC (LON:IDH) was upgraded by N+1 Singer to a “hold” rating in a research note issued on Thursday. The firm currently has a GBX 480 ($8.02) price objective on the stock, down from their previous price objective of GBX 525 ($8.78). N+1 Singer’s price objective suggests a potential upside of 0.89% from the stock’s previous close.
Immunodiagnostic Systems Hldgs PLC (LON:IDH) opened at 492.00 on Thursday. Immunodiagnostic Systems Hldgs PLC has a 1-year low of GBX 422.00 and a 1-year high of GBX 593.00. The stock has a 50-day moving average of GBX 513.5 and a 200-day moving average of GBX 522.8.
A number of other firms have also recently commented on IDH. Analysts at Panmure Gordon reiterated a “hold” rating on shares of Immunodiagnostic Systems Hldgs PLC in a research note on Thursday. They now have a GBX 600 ($10.03) price target on the stock. Separately, analysts at Canaccord Genuity cut their price target on shares of Immunodiagnostic Systems Hldgs PLC from GBX 492 ($8.22) to GBX 478 ($7.99) in a research note on Tuesday, August 12th. They now have a “hold” rating on the stock. Six analysts have rated the stock with a hold rating, The stock has an average rating of “Hold” and an average price target of GBX 509.33 ($8.51).
Immunodiagnostic Systems Holdings plc (LON:IDH) is engaged in manufacturing and distributing medical diagnostic products.
Receive News & Ratings for Immunodiagnostic Systems Hldgs PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Immunodiagnostic Systems Hldgs PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.